Anemocyte is a Biotech Manufacturing Organization (BMO); a biotech company active in the field of Cell and Gene Therapies (CGTs) that addresses CGT needs pro-actively offering one stop shop solutions and fostering exciting innovations.
- Process development and GMP capabilities (Somatic Cells, Non-Viral Modified Cells, Vesicles)
- Plasmids for Viral Vector Manufacturing.
- Project 2020: to address up to commercial scale needs for CGTs Including Viral Vectors modified cells.
- Big Data Analysis of CGTs
- 14 years of GMP manufacturing of CGTs and biological drugs;
- 61 years of Contract Manufacturing within our Group (Holding F.I.S.)